{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-105298","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.091727+00:00","generated_at":"2026-05-17T00:50:28.252081+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Iradimed reports record Q3 revenue of $21.2M, up 16% YoY; raises FY2025 guidance","bullets":["GAAP diluted EPS $0.43, non-GAAP diluted EPS $0.47; net income $5.6M (+10% YoY).","Full-year 2025 guidance raised: revenue $82.5M-$83.5M, GAAP EPS $1.68-$1.72, non-GAAP EPS $1.84-$1.88.","Declares quarterly dividend of $0.17/share, payable Nov 25, 2025, record date Nov 14, 2025.","Next-generation 3870 MRI-compatible IV pump on track for limited commercial shipments Dec 2025, full rollout Q1 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-105298","json":"https://secwatch.observer/filing/0001104659-25-105298.json","markdown":"https://secwatch.observer/filing/0001104659-25-105298.md","text":"https://secwatch.observer/filing/0001104659-25-105298.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000110465925105298/0001104659-25-105298-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000110465925105298/irmd-20251103x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:50:28.252081+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}